Rodger Novak is President of CRISPR Therapeutics AG. Currently has a direct ownership of 573,007 shares of CRSP, which is worth approximately $26.6 Million. The most recent transaction as insider was on Jun 30, 2021, when has been sold 25,000 shares (Common Shares) at a price of $165.0 per share, resulting in proceeds of $4,125,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 573K
0% 3M change
0% 12M change
Total Value Held $26.6 Million

Rodger Novak Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2021
SELL
Open market or private sale
$4,125,000 $165.0 p/Share
25,000 Reduced 4.18%
573,007 Common Shares
Jun 28 2021
SELL
Open market or private sale
$3,913,750 $156.55 p/Share
25,000 Reduced 4.01%
598,007 Common Shares
Jun 21 2021
SELL
Open market or private sale
$3,201,750 $128.07 p/Share
25,000 Reduced 3.86%
623,007 Common Shares
Nov 30 2020
SELL
Open market or private sale
$12,500,000 $125.0 p/Share
100,000 Reduced 13.37%
648,007 Common Shares
Nov 30 2020
BUY
Exercise of conversion of derivative security
$1,422,000 $14.22 p/Share
100,000 Added 12.53%
698,007 Common Shares
Oct 09 2020
SELL
Open market or private sale
$276,200 $100.0 p/Share
2,762 Reduced 0.42%
648,007 Common Shares
Oct 09 2020
BUY
Exercise of conversion of derivative security
$39,856 $14.43 p/Share
2,762 Added 0.42%
650,769 Common Shares
Oct 08 2020
SELL
Open market or private sale
$2,223,800 $100.0 p/Share
22,238 Reduced 3.32%
648,007 Common Shares
Oct 08 2020
BUY
Exercise of conversion of derivative security
$320,894 $14.43 p/Share
22,238 Added 3.21%
670,245 Common Shares
Sep 01 2020
SELL
Open market or private sale
$2,311,000 $92.44 p/Share
25,000 Reduced 3.71%
648,007 Common Shares
Sep 01 2020
BUY
Exercise of conversion of derivative security
$355,500 $14.22 p/Share
25,000 Added 3.58%
673,007 Common Shares
Aug 19 2020
SELL
Open market or private sale
$2,500,000 $100.0 p/Share
25,000 Reduced 3.71%
648,007 Common Shares
Aug 19 2020
BUY
Exercise of conversion of derivative security
$350,000 $14.0 p/Share
25,000 Added 3.58%
673,007 Common Shares
Jul 07 2020
SELL
Open market or private sale
$2,250,000 $90.0 p/Share
25,000 Reduced 3.71%
648,007 Common Shares
Jul 07 2020
BUY
Exercise of conversion of derivative security
$197,750 $7.91 p/Share
25,000 Added 3.58%
673,007 Common Shares
Jul 01 2020
SELL
Open market or private sale
$4,000,000 $80.0 p/Share
50,000 Reduced 7.16%
648,007 Common Shares
Jun 23 2020
SELL
Open market or private sale
$3,750,000 $75.0 p/Share
50,000 Reduced 6.68%
698,007 Common Shares
May 26 2020
SELL
Open market or private sale
$2,573,006 $70.27 p/Share
36,616 Reduced 4.67%
748,007 Common Shares
May 22 2020
SELL
Open market or private sale
$937,014 $70.01 p/Share
13,384 Reduced 1.68%
784,623 Common Shares
May 19 2020
SELL
Open market or private sale
$3,250,000 $65.0 p/Share
50,000 Reduced 5.9%
798,007 Common Shares
Nov 19 2019
SELL
Open market or private sale
$2,353,260 $70.0 p/Share
33,618 Reduced 100.0%
0 Common Shares
Nov 19 2019
BUY
Exercise of conversion of derivative security
$485,108 $14.43 p/Share
33,618 Added 50.0%
33,618 Common Shares
Jul 10 2019
SELL
Open market or private sale
$2,500,000 $50.0 p/Share
50,000 Reduced 5.57%
848,007 Common Shares
Jun 10 2019
SELL
Open market or private sale
$2,250,000 $45.0 p/Share
50,000 Reduced 5.27%
898,007 Common Shares
Mar 04 2019
SELL
Open market or private sale
$3,152,147 $41.19 p/Share
76,527 Reduced 7.47%
948,007 Common Shares
RN

Rodger Novak

President
Cambridge, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Track Activities on CRSP